---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-007616"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:22:44.967655+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Pure Bioscience shareholders approve increase in authorized shares to 250M

## Summary
- Approved amendment increasing authorized common shares from 200M to 250M, with 63.87% of outstanding shares voting for.
- Elected 7 directors, each receiving over 96% of votes cast.
- Ratified Weinberg & Company as auditor for FY 2026 (99.81% approval).
- Advisory vote on executive compensation passed with 96.68% support.

## SEC filing metadata
- accession: 0001493152-26-007616
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315226007616/0001493152-26-007616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315226007616/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-007616
- JSON: https://secwatch.observer/filing/0001493152-26-007616.json
- Plain text: https://secwatch.observer/filing/0001493152-26-007616.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.